Beyond glycoproteins as galectin counterreceptors: Effector T cell growth control of tumors via ganglioside GM1

Annals of the New York Academy of Sciences

Volumn 1253, Issue 1, 2012, Pages 206-221

  Ledeen, Robert W ^a   Wu, Gusheng ^a   André, Sabine ^b   Bleich, David ^a   Huet, Guillemette ^c   Kaltner, Herbert ^b   Kopitz, Jürgen ^d   Gabius, Hans Joachim ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anoikis; Carcinoma; Diabetes; Galectin 1; Glycosphingolipid; GM1 ganglioside; Immune suppression; T cells

Indexed keywords

ALPHA5 INTEGRIN; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GALECTIN 1; GALECTIN 4; GANGLIOSIDE GM1; GLUCOSYLCERAMIDE; GLYCOPROTEIN; SIALIC ACID; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5;

ANTIGEN PRESENTING CELL; APOPTOSIS; BINDING AFFINITY; CALCIUM TRANSPORT; CANCER CONTROL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL CYCLE ARREST; CELL GROWTH; CELL MEMBRANE; CELL SURFACE; CROSS LINKING; EFFECTOR CELL; FUCOSYLATION; GROWTH REGULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

ERAGROSTIS TEF; MUS;

EID: 84860251714     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06479.x     Document Type: Review

References (122)

1. Gabius, H.-J. Ed. 2009. The Sugar Code. Fundamentals of Glycosciences. Wiley-VCH. Weinheim, Germany.
2. Laine, R.A. 1997. The information-storing potential of the sugar code. In Glycosciences: Status and Perspectives. H.-J. Gabius & S. Gabius, Eds.: 1-14. Chapman & Hall. London/Weinheim.
3. Zuber, C. & J. Roth. 2009. N-Glycosylation. In The Sugar Code. Fundamentals of Glycosciences. H.-J. Gabius, Ed.: 87-110. Wiley-VCH. Weinheim, Germany.
4. Gahmberg, C.G. & M. Tolvanen. 1996. Why mammalian cell surface proteins are glycoproteins. Trends Biochem. Sci. 21: 308-311.
5. Zielinska, D.F., F. Gnad, J.R. Wisniewski & M. Mann. 2010. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141: 897-907.
6. Patsos, G. & A. Corfield. 2009. O-Glycosylation: structural diversity and function. In The Sugar Code. Fundamentals of Glycosciences. H.-J. Gabius, Ed.: 111-137. Wiley-VCH. Weinheim, Germany.
7. Haltiwanger, R.S. & J.B. Lowe. 2004. Role of glycosylation in development. Annu. Rev. Biochem. 73: 491-537.
8. Patsos, G., S. André, N. Roeckel, et al. 2009. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 19: 726-734.
9. van de Wouwer, M., S. André, H.-J. Gabius & A. Villalobo. 2011. Nitric oxide changes distinct aspects of the glycophenotype of human neuroblastoma NB69 cells. Nitric Oxide 24: 91-101.
10. André, S., T. Kozár, S. Kojima, C. Unverzagt & H.-J. Gabius. 2009. From structural to functional glycomics: core substitutions as molecular switches for shape and lectin affinity of N-glycans. Biol. Chem. 390: 557-565.
11. Cummings, R.D. 2009. The repertoire of glycan determinants in the human glycome. Mol. BioSyst. 5: 1087-1104.
12. Parker, R.B. & J.J. Kohler. 2010. Regulation of intracellular signaling by extracellular glycan remodeling. ACS Chem. Biol. 5: 35-46.
13. Gabius, H.-J., S. André, J. Jiménez-Barbero, A. Romero & D. Solís. 2011. From lectin structure to functional glycomics: principles of the sugar code. Trends Biochem. Sci. 36: 298-313.
14. Brewer, C.F., M.C. Miceli & L.G. Baum. 2002. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 12: 616-623.
15. Rabinovich, G.A., M.A. Toscano, S.S. Jackson & G.R. Vasta. 2007. Functions of cell surface galectin-glycoprotein lattices. Curr. Opin. Struct. Biol. 17: 513-520.
16. Boscher, C., J.W. Dennis, I.R. Nabi. 2011. Glycosylation, galectins and cellular signaling. Curr. Opin. Cell Biol. 23: 383-392.
17. Kaltner, H. & H.-J. Gabius. 2012. A toolbox of lectins for translating the sugar code: the galectin network in phylogenesis and tumors. Histol. Histopathol. 27: 397-416.
18. López-Lucendo, M.F., D. Solís, S. André, et al. 2004. Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J. Mol. Biol. 343: 957-970.
19. 1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J. Biol. Chem. 280: 37266-37277.
20. 1-integrin. Cell Death Differ. 18: 806-816.
21. Amano, M., M. Galvan, J. He & L.G. Baum. 2003. The ST6Gal1 sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J. Biol. Chem. 278: 7469-7475.
22. H-17 effector cells selectively regulates susceptibility to cell death. Nature Immunol. 8: 825-834.
23. INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 274: 3233-3256.
24. 1 fibronectin receptor. J. Cell Biol. 150: 1467-1478.
25. INK4a: downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J. 277: 3552-3563.
26. Villalobo, A., A. Nogales-Gonzáles & H.-J. Gabius. 2006. A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci. Glycotechnol. 18: 1-37.
27. Garner, O.B. & L.G. Baum. 2008. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem. Soc. Trans. 36: 1472-1477.
28. Bi, S. & L.G. Baum. 2009. Sialic acids in T cell development and function. Biochim. Biophys. Acta 1790: 1599-1610.
29. Blasko, A., R. Fajka-Boja, G. Ion & E. Monostori. 2011. How does it act when soluble? Critical evaluation of mechanism of galectin-1 induced T-cell apoptosis. Acta Biol. Hung. 62: 106-111.
30. Merrill, A.H., Jr., M.D. Wang, M. Park & M.C. Sullards. 2007. (Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends Biochem. Sci. 32: 457-468.
31. Kopitz, J. 2009. Glycolipids. In The Sugar Code. Fundamentals of Glycosciences. H.-J. Gabius, Ed.: 177-198. Wiley-VCH. Weinheim, Germany.
32. Ledeen, R.W. & G. Wu. 2009. Neurobiology meets glycosciences. In The Sugar Code. Fundamentals of Glycosciences. H.-J. Gabius, Ed.: 495-516. Wiley-VCH. Weinheim, Germany.
33. Lopez, P.H. & R.L. Schnaar. 2009. Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 19: 549-557.
34. Yu, R.K., M. Yanagisawa & T. Ariga. 2007. Glycosphingolipid structures. In Comprehensive Glycoscience. J.P. Kamerling, Ed.: 73-122. Elsevier. Oxford, UK.
35. Svennerholm, L. 1976. Interaction of cholera toxin and ganglioside G(M1). Adv. Exp. Med. Biol. 71: 191-204.
36. Ledeen, R.W. & G. Wu. 2010. In search of a solution to the Sphinx-like riddle of GM1. Neurochem. Res. 35: 1867-1874.
37. Miyagi, T., T. Wada, A. Iwamatsu, et al. 1999. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J. Biol. Chem. 274: 5004-5011.
38. Durrie, R., M. Saito & A. Rosenberg. 1988. Endogenous glycosphingolipid acceptor specificity of sialosyltransferase systems in intact Golgi membranes, synaptosomes, and synaptic plasma membranes from rat brain. Biochemistry 27: 3759-3764.
39. Prinetti, A., V. Chigorno, L. Mauri, et al. 2007. Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane. J. Neurochem. 103(Suppl 1): 113-125.
40. Nomenclature of Glycolipids. International Union of Pure and Applied Chemistry. Available at:.
41. Mutoh, T., T. Hamano, S. Yano, et al. 2002. Stable transfection of GM1 synthase gene into GM1-deficient NG108-15 cells, CR-72 cells, rescues the responsiveness of Trk-neurotrophin receptor to its ligand, NGF. Neurochem. Res. 27: 801-806.
42. Xie, X., G. Wu, Z.H. Lu & R.W. Ledeen. 2002. Potentiation of a sodium-calcium exchanger in the nuclear envelope by nuclear GM1 ganglioside. J. Neurochem. 81: 1185-1195.
43. Wu, G., Z.H. Lu & R.W. Ledeen. 1997. Interaction of the {eth}-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode. Mol. Brain Res. 44: 341-346.
44. Facci, L., A. Leon, G. Toffano, et al. 1984. Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J. Neurochem. 42: 299-305.
45. Ledeen, R.W. 1984. Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12: 147-159.
46. Ledeen, R.W., G.S. Wu, Z.H. Lu, D. Kozireski-Chubak & Y. Fang. 1998. The role of GM1 and other gangliosides in neuronal differentiation - overview and new findings. Ann. NY Acad. Sci. 845: 341-348.
47. Abad-Rodriguez, J. & A. Robotti. 2007. Regulation of axonal development by plasma membrane gangliosides. J. Neurochem. 103(Suppl 1): 47-55.
48. Schengrund, C.L. & M.A. Repman. 1982. Density-dependent changes in gangliosides and sialidase activity of murine neuroblastoma cells. J. Neurochem. 39: 940-947.
49. Kopitz, J., C. von Reitzenstein, C. Mühl & M. Cantz. 1994. Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation. Biochem. Biophys. Res. Comm. 199: 1188-1193.
50. Kopitz, J., C. von Reitzenstein, K. Sinz & M. Cantz. 1996. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells. Glycobiology 6: 367-376.
51. Kopitz, J., C. Mühl, V. Ehemann, et al. 1997. Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells. Eur. J. Cell Biol. 73: 1-7.
52. 1 is a ligand for specific binding sites in various human tumor cell types and peripheral blood lymphocytes and monocytes. Biochem. Biophys. Res. Commun. 169: 239-244.
53. 1) glycoligands in nasal polyps and other human lesions including neoplasms. Histol. Histopathol. 11: 985-992.
54. Caron, M., R. Joubert-Caron, J.R. Cartier, et al. 1993. Study of lectin-ganglioside interactions by high-performance liquid affinity chromatography. J. Chromatography 646: 327-333.
55. 1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J. Biol. Chem. 273: 11205-11211.
56. Kopitz, J., C. von Reitzenstein, S. André, et al. 2001. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J. Biol. Chem. 276: 35917-35923.
57. Kopitz, J., M. Bergmann & H.-J. Gabius. 2010. How adhesion/growth-regulatory galectins-1 and -3 attain cell specificity: case study defining their target on neuroblastoma cells (SK-N-MC) and marked affinity regulation by affecting microdomain organization of the membrane. IUBMB Life 62: 624-628.
58. 1 versus bacterial toxins. Biochemistry 42: 14762-14773.
59. 1in silico and in vitro on human neuroblastoma cells. Int. J. Cancer 114: 46-57.
60. Solís, D., A. Romero, M. Menéndez & J. Jiménez-Barbero. 2009. Protein-carbohydrate interactions: basic concepts and methods for analysis. In The Sugar Code. Fundamentals of Glycosciences. H.-J. Gabius, Ed.: 233-245. Wiley-VCH. Weinheim, Germany.
61. Kalka, D., C. von Reitzenstein, J. Kopitz & M. Cantz. 2001. The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts. Biochem. Biophys. Res. Commun. 283: 989-993.
62. Hirabayashi, J., T. Hashidate, Y. Arata, et al. 2002. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572: 232-254.
63. Inokuchi, J.-I. & K. Kabayama. 2008. Modulation of growth factors receptors in membrane microdomains. Trends Glycosci. Glycotechnol. 20: 353-371.
64. Ichikawa, N., K. Iwabuchi, H. Kurihara, et al. 2009. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J. Cell Sci. 122: 289-299.
65. Fajka-Boja, R., A. Blasko, F. Kovacs-Solyom, et al. 2008. Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis. Cell. Mol. Life Sci. 65: 2586-2593.
66. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18: 1197-1209.
67. + T cells. Blood 109: 2058-2065.
68. Wang, J., Z.H. Lu, H.-J. Gabius, et al. 2009. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J. Immunol. 182: 4036-4045.
69. Tuosto, L., I. Parolini, S. Schroder, et al. 2001. Organization of plasma membrane functional rafts upon T cell activation. Eur. J. Immunol. 31: 345-349.
70. Brumeanu, T.D., A. Preda-Pais, C. Stoica, et al. 2007. Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cells. Mol. Immunol. 44: 530-540.
71. Wang, P., J. Zhang, H. Bian, et al. 2004. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem. J. 380: 425-433.
72. Sobel, D.O., B. Yankelevich, D. Goyal, et al. 1998. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes 47: 186-191.
73. Williams, N.A., T.R. Hirst & T.O. Nashar. 1999. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today 20: 95-101.
74. Salmond, R.J., J.A. Luross & N.A. Williams. 2002. Immune modulation by the cholera-like enterotoxins. Expert Rev. Mol. Med. 4: 1-16.
75. Roda, O., E. Ortiz-Zapater, N. Martín-Bosch, et al. 2009. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancratic cancer. Gastroenterology 136: 1379-1390.
76. Dixon, S.J., D. Stewart, S. Grinstein & S. Spiegel. 1987. Transmembrane signaling by the B subunit of cholera toxin: increased cytoplasmic free calcium in rat lymphocytes. J. Cell Biol. 105: 1153-1161.
77. Gouy, H., P. Deterre, P. Debre & G. Bismuth. 1994. Cell calcium signaling via GM1 cell surface gangliosides in the human Jurkat T cell line. J. Immunol. 152: 3271-3281.
78. Walzel, H., M. Blach, J. Hirabayashi, et al. 2000. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 10: 131-140.
79. Clapham, D.E., L.W. Runnels & C. Strubing. 2001. The TRP ion channel family. Nat. Rev. Neurosci. 2: 387-396.
80. 2+ channel. J. Neurosci. Res. 69: 669-680.
81. 1 integrin initiates neurite outgrowth. J. Neurosci. 27: 7447-7458.
82. Anderson, M.S. & J.A. Bluestone. 2005. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485.
83. + regulatory T cells. J. Immunol. 181: 7350-7355.
84. D'Alise, A.M., V. Auyeung, M. Feuerer, et al. 2008. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA 105: 19857-19862.
85. Wu, G., Z.H. Lu, H.-J. Gabius, et al. 2011. Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T cell suppression. Diabetes 60: 2341-2349.
86. + T cells in autoimmunity. Curr. Opin. Immunol. 17: 624-631.
87. + T cells. BMC Immunol. 5: 2.
88. + T lymphocytes. Int. Immunol. 15: 731-736.
89. Wu, G. & R.W. Ledeen. 1994. Gangliosides as modulators of neuronal calcium. Progr. Brain Res. 101: 101-112.
90. Vieira, K.P., A.R. de Almeida e Silva Lima Zollner, C. Malaguti, et al. 2008. Ganglioside GM1 effects on the expression of nerve growth factor (NGF), Trk-A receptor, proinflammatory cytokines and on autoimmune diabetes onset in non-obese diabetic (NOD) mice. Cytokine 42: 92-104.
91. Shimada, K., C.S. Koh, K. Uemura & N. Yanagisawa. 1994. Suppression of experimental allergic encephalomyelitis in Lewis rats by administration of gangliosides. Cell. Immunol. 154: 231-239.
92. Sekiguchi, Y., M. Ichikawa, A. Inoue, et al. 2001. Brain-derived gangliosides suppress the chronic relapsing-remitting experimental autoimmune encephalomyelitis in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. J. Neuroimmunol. 116: 196-205.
93. Monteiro de Castro, G., M. Eduarda Zanin, D. Ventura-Oliveira, et al. 2004. Th1 and Th2 cytokine immunomodulation by gangliosides in experimental autoimmune encephalomyelitis. Cytokine 26: 155-163.
94. Ponzin, D., A.M. Menegus, G. Kirschner, et al. 1991. Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system. Ann. Neurol. 30: 678-685.
95. Ledeen, R.W., B. Oderfeld-Nowak, C.F. Brosnan & A. Cervone. 1990. Gangliosides offer partial protection in experimental allergic neuritis. Ann. Neurol. 27(Suppl): S69-S74.
96. Cha, S.K., B. Ortega, H. Kurosu, et al. 2008. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc. Natl. Acad. Sci. USA 105: 9805-9810.
97. Chen, I.-J., H.-L. Chen & M. Demetriou. 2007. Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling. J. Biol. Chem. 282: 35361-35372.
98. Lau, K.S., E.A. Partridge, A. Grigorian, et al. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129: 123-134.
99. Demetriou, M., M. Granovsky, S. Quaggin & J.W. Dennis. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733-739.
100. Gabius, H.-J. 2006. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit. Rev. Immunol. 26: 43-79.
101. Sturm, A., M. Lensch, S. André, et al. 2004. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J. Immunol. 173: 3825-3837.
102. Kopitz, J., S. André, C. von Reitzenstein, et al. 2003. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22: 6277-6288.
103. Danielsen, E.M. & B. van Deurs. 1997. Galectin-4 and small intestinal brush border enzymes form clusters. Mol. Biol. Cell 8: 2241-2251.
104. Danielsen, E.M. & G.H. Hansen. 2006. Lipid raft organization and function in brush borders of epithelial cells. Mol. Membr. Biol. 23: 71-79.
105. Delacour, D., V. Gouyer, J.-P. Zanetta, et al. 2005. Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J. Cell Biol. 169: 491-501.
106. Stechly, L., W. Morelle, A.F. Dessein, et al. 2009. Galectin-4-regulated delivery of glycoproteins to the brush border membrane of enterocyte-like cells. Traffic 10: 438-450.
107. Wu, A.M., J.H. Wu, J.-H. Liu, et al. 2004. Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the β-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 86: 317-326.
108. Dam, T.K., H.-J. Gabius, S. André, et al. 2005. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 44: 12564-12571.
109. Ideo, H., A. Seko & K. Yamashita. 2005. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J. Biol. Chem. 280: 4730-4737.
110. Morelle, W., L. Stechly, S. André, et al. 2009. Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking. Biol. Chem. 390: 529-544.
111. Hughes, R.C. 1999. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1473: 172-185.
112. Aruffo, A., W. Kolanus, G. Walz, et al. 1991. CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell 67: 35-44.
113. Suzuki, Y., Y. Toda, T. Tamatani, et al. 1993. Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain. Biochem. Biophys. Res. Commun. 190: 426-434.
114. Garcia, J., N. Callewaert & L. Borsig. 2007. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology 17: 185-196.
115. Jeon, S.-B., H.J. Yoon, S.-H. Park, et al. 2008. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J. Immunol. 181: 8077-8087.
116. Purkrábková, T., K. Smetana Jr., B. Dvoránková, et al. 2003. New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol. Cell 95: 535-545.
117. Smetana Jr., K., B. Dvoránková, M. Chovanec, et al. 2006. Nuclear presence of adhesion/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem. Cell Biol. 125: 171-182.
118. Ledeen, R.W. & G. Wu. 2007. GM1 in the nuclear envelope regulates nuclear calcium through association with a nuclear sodium-calcium exchanger. J. Neurochem. 103(Suppl 1): 126-134.
119. Haudek, K.C., K.J. Spronk, P.G. Voss, et al. 2010. Dynamics of galectin-3 in the nucleus and cytoplasm. Biochim. Biophys. Acta 1800: 181-189.
120. Kodet, O., B. Dvoránková, L. Lacina, et al. 2011. Comparative analysis of nuclear presence of adhesion/growth-regulatory galectins and galectin reactivity in interphasic and mitotic cells. Folia Biol. (Praha) 57: 125-132.
121. Ledeen, R.W. & G. Wu. 2011. New findings on nuclear gangliosides: overview on metabolism and function. J. Neurochem. 116: 714-720.
122. Gabius, H.-J. 2009. Animal and human lectins. In The Sugar Code. Fundamentals of Glycosciences. H.-J. Gabius, Ed.: 317-328. Wiley-VCH. Weinheim, Germany.